News » AIDS

1 thru 10 of 1216 Stories
Experts Focus on Innovative Solutions to Speed Progress Against HIV Among Youth

Experts Focus on Innovative Solutions to Speed Progress Against HIV Among Youth

Jul 27
The world has made great strides in reducing the impact of HIV, and AIDS-related deaths are on the decline in every age group -- except among adolescents. New UNAIDS estimates show that young people continue to be at elevated risk for HIV globally.

Drugmaker GSK Reviewing its R&D Programs Under New CEO

Drugmaker GSK Reviewing its R&D Programs Under New CEO

Jul 27
Drugmaker GlaxoSmithKline says it will halt some 30 clinical and pre-clinical programs as it reviews its research and development pipeline and focuses on improving efficiency.

IAS Honors Outstanding Research, Promising Young Investigators, and Pioneering Efforts to Address HIV Stigma

IAS Honors Outstanding Research, Promising Young Investigators, and Pioneering Efforts to Address HIV Stigma

Jul 27
Leadership in HIV research and efforts to improve access to HIV prevention and treatment were recognized through prizes and awards presented at the 9th IAS Conference on HIV Science.

Positive Phase 3 Data for Darunavir-based Single Tablet Regimen for HIV

Positive Phase 3 Data for Darunavir-based Single Tablet Regimen for HIV

Jul 26
Yesterday, in an oral session at the 9th International AIDS Society Conference on HIV Science in Paris, Janssen-Cilag International NV announced that an investigational single-tablet regimen (STR) containing darunavir is effective and well tolerated.

Studies Show Progress in Finding New HIV Prevention Options and Implementing Existing Approaches

Studies Show Progress in Finding New HIV Prevention Options and Implementing Existing Approaches

Jul 26
Researchers released data from five cutting-edge studies that show progress across several major HIV prevention approaches at an official press conference at the 9th IAS Conference on HIV Science.

CIPHER Grants and Fellowships Encourage Innovative Responses To Pediatric And Adolescent HIV

CIPHER Grants and Fellowships Encourage Innovative Responses To Pediatric And Adolescent HIV

Jul 26
The International AIDS Society's (IAS's) Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) has awarded research grants to six exceptional early-stage investigators at the 9th IAS Conference on HIV Science.

Study Finds Effective HIV Treatment Halts Transmission Among Same-Sex Couples

Study Finds Effective HIV Treatment Halts Transmission Among Same-Sex Couples

Jul 26
Results from the largest study to analyze HIV transmission risk among homosexual couples with differing HIV status have shown that HIV-positive men who are on treatment that makes the virus undetectable, do not transmit HIV to their partners.

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen

Jul 26
Janssen Sciences announced that a regimen of two investigational long-acting, injectable formulations of HIV medicines was as effective as 3-drug ART.

HIV Epidemic 'Coming Under Control' in Nation with Top Rate

HIV Epidemic 'Coming Under Control' in Nation with Top Rate

Jul 26
The United States government says the HIV epidemic is "coming under control" in the country with the world's highest prevalence of HIV, Swaziland.

Gilead Announces Phase 3 Results for Investigational Fixed-Dose HIV Treatment

Gilead Announces Phase 3 Results for Investigational Fixed-Dose HIV Treatment

Jul 25
Gilead Sciences, Inc. announced detailed 48-week results from two Phase 3 studies evaluating the efficacy and safety of a fixed-dose combination of HIV meds.

1 thru 10 of 1216 Stories